UC Investments

Activity from announced rounds

All recorded activity

UC Investments is the University of California investment office identified as co-lead by TEKEVER.

Recorded funding activity

TEKEVER develops autonomous aircraft. Other recorded activity includes Unrivaled’s basketball league and Prenosis’ critical-care diagnostics. The office remains distinct from specifically named UC funds.

Sources
Rounds participated in
6
Confirmed lead rounds
1
3 roles undisclosed
New companies
6
First participation on record · 0 follow-on
Funding in participating rounds
$1B
6 disclosed · full round size, not this investor’s share

By stage

Series C+3
Series A2
Series B1

By primary sector

Biotech2
AI1
Consumer1
Healthtech1
Robotics1

By country

United States5
Portugal1

Rounds

6 in all activity
Delix Therapeutics

Delix Therapeutics develops neuroplastogen medicines for psychiatric and neurological disorders.

$100MSeries C
Participant
Remedy Robotics

Remedy Robotics develops AI-enabled robotic systems for endovascular procedures, aiming to extend specialist cardiovascular care to more hospitals.

$62MSeries B
Participant
TEKEVER

TEKEVER develops autonomous uncrewed aircraft and mission systems that give public agencies and defense customers persistent intelligence from the air.

$580MSeries D
Lead
Unrivaled

Professional women's basketball league with player equity and ownership model

$100MSeries C
Role not disclosed
Prenosis

Develops integrated diagnostics and therapeutics for critical care conditions

$20MSeries A
Role not disclosed
Arena

Arena evaluates AI models through comparisons and observations of how people use them in real tasks.

$150MSeries A
Role not disclosed